Andreas Hillarp
- Researcher; PhD
Publications 2022
An international study on activated partial thromboplastin time prolongation. Part 1: Analytical results
Clin Chim Acta, 535, 167-173 (in press)
DOI 10.1016/j.cca.2022.08.024, PubMed 36041550
An international study on activated partial thromboplastin time prolongation. Part 2: Interpretative commenting
Clin Chim Acta, 535, 174-179 (in press)
DOI 10.1016/j.cca.2022.08.026, PubMed 36055391
[Routine screening with APTT is not indicated before surgery]
Lakartidningen, 119
PubMed 35713306
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex
Thromb Res, 213, 97-104
DOI 10.1016/j.thromres.2022.03.013, PubMed 35316719
Rapid Detection of Apixaban by a ROTEM-Based Approach and Reversibility with Andexanet Alfa or DOAC-Stop
TH Open, 6 (3), e238-e247
DOI 10.1055/s-0042-1751072, PubMed 36046206
Publications 2021
Presentation and formatting of laboratory results: a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group "postanalytical phase" (WG-POST)
Crit Rev Clin Lab Sci, 58 (5), 329-353
DOI 10.1080/10408363.2020.1867051, PubMed 33538219
Haemoglobin and red blood cell reference intervals during infancy
Arch Dis Child, 107 (4), 351-358
DOI 10.1136/archdischild-2021-321672, PubMed 34674992
Serum amyloid P component: a new biomarker for low sperm concentration?
Asian J Androl, 23 (5), 450-455
DOI 10.4103/aja.aja_7_21, PubMed 33723096
Publications 2020
Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays
J Thromb Haemost, 18 (8), 1866-1873
DOI 10.1111/jth.14829, PubMed 32294291
Soluble Transferrin Receptor during infancy and reference intervals for the Roche Cobas platform
Int J Lab Hematol, 43 (3), 378-386
DOI 10.1111/ijlh.13391, PubMed 33217104
Publications 2019
When age really matters; ferritin reference intervals during infancy revisited
Scand J Clin Lab Invest, 79 (8), 590-594
DOI 10.1080/00365513.2019.1681028, PubMed 31642699
Publications 2018
Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
Scand J Clin Lab Invest, 78 (7-8), 575-583
DOI 10.1080/00365513.2018.1522664, PubMed 30278787
Publications 2017
Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments
Thromb Res, 159, 19-23
DOI 10.1016/j.thromres.2017.09.012, PubMed 28950216
Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD - A longitudinal study
PLoS One, 12 (12), e0190007
DOI 10.1371/journal.pone.0190007, PubMed 29272282
Publications 2016
Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report
Biochem Med (Zagreb), 26 (2), 279-84
DOI 10.11613/BM.2016.033, PubMed 27346976
Intraoperative Hydroxyethyl Starch and its Effects on Different Fibrinogen Measurements
Clin Appl Thromb Hemost, 22 (7), 641-7
DOI 10.1177/1076029616632904, PubMed 26893443
Publications 2015
Perioperative changes in PIVKA-II
Scand J Clin Lab Invest, 75 (7), 562-7
DOI 10.3109/00365513.2015.1058521, PubMed 26198297
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome and Thrombosis
J Rheumatol, 42 (10), 1786-93
DOI 10.3899/jrheum.150185, PubMed 26276971
Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotension
J Hypertens, 33 (8), 1594-601
DOI 10.1097/HJH.0000000000000595, PubMed 26136066
More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
Thromb Res, 135 (3), 544-7
DOI 10.1016/j.thromres.2014.12.019, PubMed 25596769
One-stage vs. chromogenic assays in haemophilia A
Eur J Haematol, 94 Suppl 77, 38-44
DOI 10.1111/ejh.12500, PubMed 25560793
Comparison of automated von Willebrand factor activity assays
Thromb Res, 135 (4), 684-91
DOI 10.1016/j.thromres.2015.01.027, PubMed 25661290
Publications 2014
Assay discrepancy in mild haemophilia A
Eur J Haematol Suppl, 76, 48-50
DOI 10.1111/ejh.12374, PubMed 24957107
Publications 2013
Long-term anti-FVIII antibody response in Bethesda-negative haemophilia A patients receiving continuous replacement therapy
Br J Haematol, 163 (3), 385-92
DOI 10.1111/bjh.12540, PubMed 24032553
Publications 2012
Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
Arthritis Res Ther, 14 (4), R185
DOI 10.1186/ar4016, PubMed 22894814
Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy
Anesth Analg, 115 (4), 890-8
DOI 10.1213/ANE.0b013e3182652a33, PubMed 22822194
Lupus anticoagulants in two children--bleeding due to nonphospholipid-dependent antiprothrombin antibodies
Eur J Pediatr, 171 (9), 1383-7
DOI 10.1007/s00431-012-1737-1, PubMed 22527568
Small and large PROS1 deletions but no other types of rearrangements detected in patients with protein S deficiency
Thromb Haemost, 108 (1), 94-100
DOI 10.1160/TH12-01-0040, PubMed 22627709
Publications 2011
[Rare hereditary types of hemophilia. Bleeding symptoms, family history and laboratory analyses indicates diagnosis]
Lakartidningen, 108 (38), 1819-23
PubMed 22111212
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia
Semin Thromb Hemost, 37 (3), 328-36
DOI 10.1055/s-0031-1274516, PubMed 21455867
Nordic Haemophilia Council's practical guidelines on diagnosis and management of von Willebrand disease
Semin Thromb Hemost, 37 (5), 495-502
DOI 10.1055/s-0031-1281034, PubMed 22102192
Determination of serum amyloid P component in seminal plasma and correlations with serum hormone levels in young, healthy men
Scand J Clin Lab Invest, 71 (7), 569-75
DOI 10.3109/00365513.2011.596567, PubMed 21988589
Publications 2010
Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study
BMC Gastroenterol, 10, 113
DOI 10.1186/1471-230X-10-113, PubMed 20920209
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
Thromb Haemost, 105 (2), 371-8
DOI 10.1160/TH10-06-0342, PubMed 21103660
[Von Willebrand disease--from biochemistry to clinical practice]
Lakartidningen, 107 (34), 1923-7
PubMed 20960954
Publications 2009
Anti-prothrombin antibodies are associated with thrombosis in children
Thromb Res, 125 (1), 19-24
DOI 10.1016/j.thromres.2009.02.007, PubMed 19303627
[Thrombocytopenia can be HIT. Heparin treatment can cause low life-threatening thrombocyte levels]
Lakartidningen, 106 (10), 682-5
PubMed 19418688
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin
Thromb Res, 124 (3), 344-8
DOI 10.1016/j.thromres.2009.03.007, PubMed 19423152
Publications 2008
[New marker in thrombotic thrombocytopenic purpura]
Ugeskr Laeger, 170 (33), 2446-9
PubMed 18761827
[ADAMTS13--actor and marker in thrombotic microangiopathy]
Lakartidningen, 105 (15), 1092-5
PubMed 18561751
Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes
Thromb Haemost, 99 (6), 1013-8
DOI 10.1160/TH07-06-0419, PubMed 18521502
[Bleeding time determination is out of date. A non-reliable method which should not be used in routine care]
Lakartidningen, 105 (17-18), 1278-83
PubMed 18561529
Publications 2007
The pentraxin serum amyloid P component is found in the male genital tract and attached to spermatozoa
Int J Androl, 31 (5), 508-17
DOI 10.1111/j.1365-2605.2007.00800.x, PubMed 17822421
Publications 2006
Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity
Clin Appl Thromb Hemost, 12 (1), 61-7
DOI 10.1177/107602960601200110, PubMed 16444436
Publications 2005
Large deletions of the PROS1 gene in a large fraction of mutation-negative patients with protein S deficiency
Thromb Haemost, 94 (5), 951-7
DOI 10.1160/TH05-06-0392, PubMed 16363235
Publications 2004
Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee
Arch Orthop Trauma Surg, 125 (1), 51-5
DOI 10.1007/s00402-004-0760-8, PubMed 15723247
Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults
Clin Orthop Relat Res (425), 168-72
PubMed 15292803
[Acetylsalicylic acid resistance--clinical diagnosis with unclear mechanism]
Lakartidningen, 101 (45), 3504-6, 3508-9
PubMed 15575422
Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme
Thromb Haemost, 91 (2), 300-7
DOI 10.1160/TH03-07-0419, PubMed 14961158
Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy
Thromb Res, 114 (2), 83-9
DOI 10.1016/j.thromres.2004.04.010, PubMed 15306149
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
Thromb Haemost, 91 (6), 1223-31
DOI 10.1160/TH03-07-0456, PubMed 15175811
INR calibration of owren-type prothombrin time based on the relationship between PT\% and INR utilizing normal plasma samples
In Thrombosis and haemostasis, Schattauer, Stuttgart, 91(2004)6, S. 1223-1231
BIBSYS 051926776
Genetic variation in the human thrombomodulin promoter locus and prognosis after acute coronary syndrome
Thromb Res, 113 (5), 319-26
DOI 10.1016/j.thromres.2004.03.010, PubMed 15183044
Publications 2003
Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H
Arch Biochem Biophys, 418 (2), 108-18
DOI 10.1016/j.abb.2003.08.018, PubMed 14522582
Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke
Thromb Res, 112 (5-6), 275-83
DOI 10.1016/j.thromres.2003.12.005, PubMed 15041270
Diagnosing protein S deficiency: analytical considerations
Clin Lab, 49 (3-4), 103-10
PubMed 12705691
Publications 2002
[Less variation in laboratory results after the introduction of INR. Differences between hospital laboratories and laboratories within primary health care are levelled out]
Lakartidningen, 99 (50), 5068-70, 5073-4
PubMed 12572298
Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein
Biochemistry, 41 (30), 9349-57
DOI 10.1021/bi025980+, PubMed 12135356